{
    "clinical_study": {
        "@rank": "129378", 
        "arm_group": {
            "arm_group_label": "ITPR", 
            "arm_group_type": "Experimental", 
            "description": "Use of the ITPR for 120 minutes."
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to evaluate the physiological response to application of the\n      Intrathoracic Pressure Regulator (ITPR) in patients with compromised cerebral circulation.\n      The study will evaluate the physiological response to intrathoracic pressure regulation\n      (IPR) therapy in hemodynamically stable patients with compromised cerebral circulation who\n      are on ventilatory support."
        }, 
        "brief_title": "Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion", 
        "condition": [
            "Head Injury", 
            "Intracranial Pathology", 
            "Compromised Cerebral Perfusion"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Craniocerebral Trauma", 
                "Brain Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u226518 years of age\n\n          -  intubated and mechanically ventilated on a volume controlled mode\n\n          -  head injury or other intracranial pathology and compromised cerebral perfusion\n\n          -  arterial line in place or alternative with continuous pressure monitoring\n\n          -  SpO2 \u226590%\n\n          -  mean arterial pressure >55\n\n          -  admission to ICU or about to undergo neurosurgery with planned placement of an\n             invasive intracranial pressure monitor\n\n          -  inclusion presents no significant delays to planned emergent neurosurgery\n\n          -  prior written informed consent\n\n        Exclusion Criteria:\n\n          -  cardiac or pulmonary injury\n\n          -  confirmed pneumothorax or hemothorax\n\n          -  serious neck injury resulting in neck swelling with jugular venous compression\n\n          -  evidence of ongoing uncontrolled bleeding\n\n          -  respiratory disease such as COPD, interstitial lung disease, or other parenchymal or\n             pulmonary vascular disease\n\n          -  marked hypertension at time of device use defined as systolic blood pressure >180\n             mmHg\n\n          -  congestive heart failure\n\n          -  women with positive serum or urine pregnancy test or breast feeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01824576", 
            "org_study_id": "ACSI 5R44NS054372", 
            "secondary_id": "5R44NS054372"
        }, 
        "intervention": {
            "arm_group_label": "ITPR", 
            "description": "Single use noninvasive device that is connected to a vacuum source and a means to deliver a positive pressure breath.  The device generates negative pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure between the periods of positive pressure ventilations.", 
            "intervention_name": "ITPR", 
            "intervention_type": "Device", 
            "other_name": [
                "Intrathoracic Pressure Regulator", 
                "CirQlator"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "ITPR", 
            "CPP", 
            "TBI", 
            "traumatic brain injury", 
            "cerebral perfusion pressure", 
            "intrathoracic pressure regulator"
        ], 
        "lastchanged_date": "April 2, 2013", 
        "number_of_arms": "1", 
        "official_title": "Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change from baseline CPP compared with the CPP during use of the ITPR.", 
            "measure": "Cerebral Perfusion Pressure (CPP)", 
            "safety_issue": "No", 
            "time_frame": "During 120 minutes of device use"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01824576"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measure change in systolic blood pressure at baseline, during ITPR treatment, and 15 minutes following removal of the ITPR", 
                "measure": "systolic blood pressure (SBP)", 
                "safety_issue": "No", 
                "time_frame": "baseline to15 minutes following device use"
            }, 
            {
                "description": "Arterial blood gases will be collected immediately following each study intervention and change will be evaluated.", 
                "measure": "Arterial blood gases", 
                "safety_issue": "Yes", 
                "time_frame": "baseline and 15 minutes after device activation"
            }, 
            {
                "description": "Measure change in diastolic blood pressure at baseline, during ITPR treatment, and 15 minutes following removal of the ITPR", 
                "measure": "Diastolic blood pressure (DBP)", 
                "safety_issue": "No", 
                "time_frame": "baseline to 15 minutes following device use"
            }, 
            {
                "description": "Measure change in mean arterial pressure at baseline, during ITPR treatment, and 15 minutes following removal of the ITPR", 
                "measure": "Mean arterial pressure (MAP)", 
                "safety_issue": "No", 
                "time_frame": "baseline to 15 minutes following device use"
            }, 
            {
                "description": "Measure change in heart rate at baseline, during ITPR treatment, and 15 minutes following removal of the ITPR", 
                "measure": "Heart rate (HR)", 
                "safety_issue": "No", 
                "time_frame": "baseline to 15 minutes following device use"
            }, 
            {
                "description": "Measure change in pulse pressure at baseline, during ITPR treatment, and 15 minutes following removal of the ITPR", 
                "measure": "Pulse pressure (PP)", 
                "safety_issue": "No", 
                "time_frame": "baseline to 15 minutes following device use"
            }, 
            {
                "description": "Measure change in EtCO2 at baseline, during ITPR treatment, and 15 minutes following removal of the ITPR", 
                "measure": "End-tidal carbon dioxide (EtCO2)", 
                "safety_issue": "No", 
                "time_frame": "baseline to 15 minutes following device use"
            }, 
            {
                "description": "Measure change in SpO2 at baseline, during ITPR treatment, and 15 minutes following removal of the ITPR", 
                "measure": "Oxygen saturation (SpO2)", 
                "safety_issue": "No", 
                "time_frame": "basseline to 15 minutes following device use"
            }
        ], 
        "source": "Advanced Circulatory Systems", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute of Neurological Disorders and Stroke (NINDS)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Advanced Circulatory Systems", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}